Dry mouth (also known as xerostomia), is a significant problem faced by adults and unless due to a side effect from medication, there is no real cure. Often the reason for a case of dry mouth isn’t known, but some common causes include medications, head and neck radiation therapy for cancer, Sjogren’s syndrome, and type…
FDA Approves First Treatment for Tardive Dyskinesia
Repetitive involuntary movements typically affecting the jaw, lips, tongue, arms or legs can be caused by tardive dyskinesia, a neurological disorder. Tardive dyskinesia is often seen as a side effect in patients taking antipsychotic medications used to treat certain mental illnesses. Previously, no medications were FDA approved to specifically treat tardive dyskinesia, making prevention key. This…
FDA Approves Renflexis, Second Biosimilar for Remicade
On April 21st, the FDA approved Renflexis (infliximab-abda), the second biosimilar to the popular medication Remicade, (infliximab) indicated for immune disorders. A biosimilar is like a generic medication in that it is less expensive than the brand name medication. However, the difference is that biosimilars are made out living cells, so they may be slightly different from their…
New Lower Prices for More Brand-Name Drugs!
Last week, GoodRx rolled out exclusive new savings on more than 40 brand-name prescriptions, and we also promised to pursue discounts for more drugs. Today, we’re happy to announce new Inside Rx discounts for 6 more brands: Colcrys (treats gout): 45% off retail price Uloric (treats gout): 16% off retail price Amitiza (treats constipation): 40% off retail…
Can Nasal Bactroban Before Surgery Prevent MRSA?
Methicillin-resistant Staphylococcus aureus (MRSA) surgical site infections have been catastrophic for patients—they result in longer hospital stays and poorer outcomes. More than 80% of the time, infections result because of Staph aureus that we are carrying, in our nose or on our skin. For those of us who may be carriers of Staph aureus (it…
FDA Updates Safety Warnings for Fluoroquinolone Antibiotics
On May 10th, 2017, the FDA issued a safety update on fluoroquinolone antibiotics, like Cipro and Levaquin, as part of an ongoing review. About a year ago, the FDA released findings that fluoroquinolone antibiotics can cause dangerous side effects involving the tendons, muscles, joints, nerves and central nervous system, and advised that use should be restricted in uncomplicated…
New FDA Approval: Tymlos for Osteoporosis
Osteoporosis affects one in four women ages 65 and older, making it more likely that you will break a bone in the hip, forearm, wrist, or spine. Osteoporosis occurs when you lose bone, don’t make enough bone, or a combination—and it can be caused by many things, including genetic makeup, diet, diseases and even some…
Illegal Cancer Treatments: FDA Warning – Fraudulent Claims of Diagnosis, Treatment, Prevention or Cure
[Posted 04/25/2017] AUDIENCE: Oncology, Patient, Consumer ISSUE: FDA issued warning letters addressed to 14 U.S.-based companies illegally selling more than 65 products that fraudulently claim to prevent, diagnose, treat or cure cancer. It is a violation of the Federal Food, Drug and Cosmetic Act to market and sell products that…
25 Percent Dextrose Injection, USP (Infant) by Hospira: Recall – Particulate Matter
[Posted 04/24/2017] AUDIENCE: Pharmacy ISSUE: Hospira is voluntarily recalling one lot of 25% Dextrose Injection, USP, (Infant) pre-filled syringe to the hospital/user level due to the presence of particulate matter, identified as human hair, found within an internal sample syringe. The affected lot is NDC: 0409-1775-10, Lot 58382EV, Expiry Date…
Phenobarbital 15 mg Tablets, USP by C.O. Truxton: Recall – Labeling Error on Declared Strength
[Posted 04/21/2017] AUDIENCE: Pharmacy, Patient ISSUE: C.O. Truxton, Inc. is voluntarily recalling lot 70952A of Phenobarbital Tablets, USP, 15 mg, to the consumer/user level. The manufacturer received a confirmed customer complaint that a bottle labeled as phenobarbital 15 mg was found to contain phenobarbital 30 mg tablets. This mislabeled product…